investor harm

Class action lawsuit filed against Picard Medical for alleged fraud involving false social media statements and insider stock sales during inflated prices.

Class action lawsuit filed against Inovio Pharmaceuticals for allegedly making false statements about device manufacturing capabilities and regulatory timelines between October 2023 and December 2025.

Ultragenyx faces class action lawsuit for allegedly misleading investors about setrusumab efficacy and failing to disclose Phase III trial risks adequately.

Ramaco Resources faces class action lawsuit for allegedly misrepresenting Brook Mine's operational status, failing to disclose lack of mining activity despite groundbreaking ceremony claims.

Class action lawsuit filed against agilon health for allegedly making false 2026 guidance claims and overstating benefits of risk reduction initiatives, affecting investors from February-August 2025.

Mereo BioPharma faces class action lawsuit over allegedly misleading disclosures about failed Phase 3 clinical trials. Investors who purchased shares between June 2023 and December 2025 may be eligible.

Class action lawsuit filed against Smart Digital Group for allegedly failing to disclose market manipulation and fraudulent promotional activities that harmed investors between May and September 2025.

REGENXBIO faces class action lawsuit alleging false statements about RGX-111 gene therapy trial results, covering securities purchased between February 2022 and January 2026.

Klarna faces class action lawsuit alleging it misrepresented loan portfolio risks and understated credit exposure in its September 2025 IPO.

Varonis Systems faces class action lawsuit alleging false statements about SaaS conversion capabilities artificially inflated stock prices, harming shareholders during February-October 2025.

Class action lawsuit filed against Sallie Mae for allegedly concealing loan delinquency increases and overstating loss mitigation effectiveness, artificially inflating stock prices during July-August 2025.

Ultragenyx Pharmaceutical faces class action lawsuit for allegedly making false statements about setrusumab drug efficacy and safety, affecting investors who bought securities between August 2023 and December 2025.

Bath & Body Works faces a class action lawsuit for allegedly making false statements about its growth strategy's effectiveness and failing to disclose poor results to investors.

Class action lawsuit filed against Fermi Inc. alleging material misrepresentations in October 2025 IPO regarding Project Matador demand and financial viability disclosures.

Class action lawsuit filed against Ardent Health for allegedly overstating Q3 2025 revenue and inflating full-year EBITDA guidance by $57.5 million due to accounting system failures.

F5 faces class action lawsuit alleging it misrepresented security capabilities and failed to disclose a major product breach affecting investors between October 2024-2025.

Sallie Mae faces class action lawsuit for allegedly failing to disclose rising loan delinquencies and overstating loss mitigation effectiveness, misleading investors about financial health.

Class action lawsuit filed against Klarna alleging its September 2025 IPO registration statement contained material misstatements about financial risk exposure and buy-now-pay-later loan portfolio risks.

Varonis Systems faces class action lawsuit alleging false statements about SaaS conversion capabilities, causing artificially inflated stock prices between February-October 2025.

Class action lawsuit filed against Ramaco Resources for allegedly making false statements about mining operations at Brook Mine facility, causing investor damages.